The impact of influenza pandemics might be overestimated; the published studies of years of life lost (YLL) have typically ignored the presence of underlying chronic conditions or health risk behaviors in most deaths. We used data on deaths involving laboratory-confirmed 2009 influenza A(H1N1) virus infection that occurred between April 2009 and May 2010 in Hong Kong, China, to adjust for these underlying risk factors. Life expectancy was corrected with hazard-based modifications to the life tables. The excess hazards posed by underlying risk factors were added to the "baseline" age-specific hazards in the local life tables to reflect the life expectancy associated with each underlying risk factor. Of 72 deceased persons with laboratory-confirmed 2009 influenza A(H1N1) virus infection, 56% had underlying risk factors. We estimated that the 2009 pandemic was associated with 1,540 (95% confidence interval: 1,350, 1,630) YLL after adjustment for age and underlying risk factors. This figure is approximately 25% lower than the YLL estimate of 2,080 derived after adjustment for age but not for risk factors. Our analysis demonstrates the potential scale of bias in YLL estimation if underlying risk factors are ignored. The estimation of YLL with correction for underlying risk factors in addition to age could also provide a framework for similar calculations elsewhere. influenza; pandemics; underlying risk factors; years of life lost Abbreviations: RSR, relative survival ratio; YLL, years of life lost.
The impact of the 2009 outbreak of pandemic influenza A(H1N1pdm09) virus (hereafter called "pH1N1") is still being assessed (1, 2) . Years of life lost (YLL) is an estimate of the average number of years a person would have lived if he or she had not died prematurely, and the sum of YLL for decedents with laboratory-confirmed influenza virus infection could be used to measure the impact of influenza epidemics under the assumption that persons who died while infected with influenza virus would have lived longer if they had not been infected. Because of the age shift in the average age of fatalities (2) (3) (4) (5) , the YLL is sometimes considered to be more reflective of the impact of a pandemic than the overall mortality rate. YLL has also been used as an outcome measure in studies of alternative vaccine allocation strategies (6, 7) . Certain underlying conditions are known to increase the risk of mortality among patients with influenza, and in one large study 62% of 2,500 laboratory-confirmed deaths involved underlying chronic health conditions (8) . In previous studies, estimates of YLL typically accounted for age at death but did not account for other underlying risk factors, including underlying chronic health conditions or health risk behaviors such as smoking. However, among persons who died at a certain age, those with underlying risk factors would have reduced YLL in comparison with those without risk factors.
Here, we provide a quantitative approach for estimating the YLL associated with the first wave of 2009 pandemic influenza A(H1N1) in Hong Kong, China, accounting for the effect on life expectancy of underlying risk factors in addition to age. This should permit more accurate quantification of the impact of influenza epidemics.
MATERIALS AND METHODS

Data sources
Individual patient data on hospitalizations and deaths among persons with laboratory-confirmed pH1N1 infection (hereafter called "confirmed deaths") occurring from April 2009 to May 2010 in Hong Kong were obtained from the Hong Kong Hospital Authority, which covers the entire Hong Kong population (7 million persons). The data included information on underlying health conditions and smoking status, demographic information such as age and sex, and epidemiologic information on illness onset, hospital admission dates, and treatment outcomes. Laboratory-confirmed pH1N1 infection was a notifiable condition throughout 2009, and laboratory capacity was sufficient to test all hospitalized patients with suspected pH1N1 infection (9) .
Statistical analysis
Life tables for the Hong Kong population in 2009 were obtained from the Hong Kong Census and Statistics Department. The YLL for confirmed deaths without underlying risk factors was estimated by reference to life expectancy at the age of death, according to local sex-specific life tables (2, 3). For each confirmed death with documented underlying risk factors such as diabetes or smoking, the YLL was corrected with hazard-based modifications to the life tables.
For each chronic condition, we reviewed the literature to obtain plausible estimates of relative survival and converted these to excess hazards. We searched for articles using the keywords for each underlying risk factor in combination with "relative survival" or "relative survival rat*" or "survival rat*" or "mortality" or "death rate" or "life expectancy." When we could not identify an estimate of the relative survival for a particular risk factor, we used the most common closely related disease or major cause of fatality in the same disease category. The relative survival ratio (RSR) of patients with risk factor d (RSR d,T ) was obtained by dividing the observed survival (S d,T ) of the study population with risk factor d by the expected survival (S g,T ) of the general population within a single followup time period T. The annual excess hazard h d for each underlying risk factor was obtained from the RSR as follows:
The excess hazards were added to the "baseline" age-specific hazards in the local life tables to reflect the additional risk of mortality associated with the chronic conditions. We assumed that this excess hazard associated with each risk factor did not vary by age and was independent of the excess hazards associated with other risk factors. The annual death rate (q d,a ) in the population at age a among persons with a certain disease d is then given by
where λ g,a is the annual hazard rate for the general population at age a. For patients with multiple risk factors, h d was replaced by the sum of the excess hazards for all relevant risk factors. With q d,a accounting for the excess hazard among the patients with underlying risk factors, we reconstructed their modified life tables and hence their modified life expectancies using the standard method. We estimated 95% confidence intervals for the YLL for each confirmed death by fitting Gompertz models to each modified life table and then using bootstrapping with 10,000 resamples. Further details on the analysis are provided in the Web Appendix (available at http://aje.oxfordjournals.org/). All analyses were conducted with R, version 2.14.1 (R Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Among 5,641 hospitalizations of patients with laboratoryconfirmed pH1N1, there were 72 confirmed deaths in Hong Kong from April 2009 through May 2010. Among the confirmed deaths, 56% (40/72) occurred among inpatients with at least 1 documented underlying risk factor. The 3 most common underlying chronic conditions among confirmed deaths were chronic pulmonary disease (16.7%), malignancies and transplantation (15.3%), and diabetes mellitus (11.1%). The ages of decedents with confirmed pH1N1 varied between <1 year and 95 years. While more than half of the hospitalized cases were less than 20 years of age, the confirmed deaths occurred predominantly in people over 50 years of age (67%) ( Table 1 and Figure 1 ). Based on the literature search, we calculated the RSR for each underlying risk factor (Table 2) (Table 3) . Middleaged adults suffered from a relatively larger loss of life years, had a higher risk of death, and were more likely to have underlying risk factors. When assessing YLL rather than the number of confirmed deaths, the impact of pH1N1 was more pronounced in this age group. Accounting for underlying risk factors led to substantial reductions in YLL estimates for older adults, and on average the YLL was reduced by a factor of 2 in persons with underlying risk factors.
DISCUSSION
It is challenging to describe comprehensively the impact of a pandemic. One metric often used to assess impact is the number of deaths associated with the pandemic (1), but this cannot capture the age shift that commonly occurs in influenza pandemics (10) . Here, we extended previous approaches to the estimation of YLL to account for underlying conditions as well as age. This is important because a high proportion of confirmed deaths occur in patients with underlying conditions, in whom influenza is most severe (8) . In Hong Kong, we estimated that failing to account for underlying conditions would have led to overestimation of the YLL, based on confirmed deaths, by approximately 25%.
The confirmed deaths are likely to be an underestimate of all "excess" deaths associated with an influenza epidemic. When assuming the same average life expectancy corrected for underlying risk factors, the YLL associated with 150 local excess deaths (11) was 46 per 100,000 population in Hong Kong, or 62 per 100,000 population if not accounting for underlying risk factors. Without accounting for underlying factors, the YLLs were estimated as 64, 96, 257, and 410 per 100,000 population in the United States, the Netherlands, Austria, and Mexico, respectively (2-5). If assuming that the same age-specific YLLs applied to seasonal influenza, we could estimate that the impact of pH1N1 in Hong Kong was lower than that of seasonal influenza, with 751 deaths annually and an average annual YLL of approximately 230 per 100,000 population (11) .
There are 2 important limitations of our analyses. First, we based estimation of YLL on virologically confirmed deaths, but deaths associated with influenza, particularly among the elderly, may have been underascertained (12), since not all influenza cases were diagnosed, tested, and virologically confirmed. Hence, our analysis corrected for the overestimation of YLL due to underlying risk factors in the subset of laboratoryconfirmed deaths only. In extensions of this work, investigators could consider the estimation of YLL based on excess deaths in populations, with population stratification not only by age Abbreviations: CI, confidence interval; COPD, chronic obstructive pulmonary disease; RSR, relative survival ratio. a S d,T represents observed survival among members of the study population with risk factor d. b S g,T represents observed survival in the general population within a single follow-up time period T. c COPD is common among fatal cases of influenza A(H1N1), and the RSR for COPD is used to represent the RSR for chronic pulmonary disease. d The RSR for coronary heart disease is used to represent the RSR for chronic cardiac disease. e Weight (kg)/height (m) 2 .
but also by the presence of underlying conditions. Second, without detailed review of individual patients' charts, it is challenging to predict life expectancy. Using an integrated epidemiologic database with information on basic medical history, we were able to make some adjustment for underlying conditions, but we did not have information on (for example) specific cancers or cancer stages, disease severity, time since onset of disease, or frequency and duration of cigarette smoking. More detailed data were not available, and we did not have access to medical charts. In extensions of this work, researchers could review in detail the patient charts of persons with confirmed deaths in order to permit more accurate prediction of potential YLL.
In conclusion, assessments of past pandemics and plans for mitigation of future pandemics, such as vaccine allocation strategies, should be based on accurate and appropriate measurement of impact. Here we have illustrated an approach to estimation of YLL that accounts for underlying health conditions and health risk behaviors in addition to age, which seems to be especially useful for middle-aged to older adults, who have a combination of relatively long YLL and a higher likelihood of comorbidity. Similar approaches could be used to examine the annual impact of seasonal influenza and could be applied to other diseases, especially those with mortality more commonly seen in people with underlying chronic conditions. This project was supported by the Harvard Center for Communicable Disease Dynamics (grant U54 GM088558 from the US National Institute of General Medical Sciences) and the Area of Excellence Scheme of the University Grants Committee of Hong Kong (grant AoE/M-12/06).
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